22 related articles for article (PubMed ID: 2560325)
1. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphoribosylpyrophosphate synthetase by 4-methoxy-(MRPP) and 4-amino-8-(D-ribofuranosylamino) pyrimido[5,4-d]pyrimidine (ARPP).
Nord LD; Willis RC; Breen TS; Avery TL; Finch RA; Sanghvi YS; Revankar GR; Robins RK
Biochem Pharmacol; 1989 Oct; 38(20):3543-9. PubMed ID: 2479382
[TBL] [Abstract][Full Text] [Related]
3. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase.
Willis RC; Nord LD; Fujitaki JM; Breen TS; Matsumoto SS
Adv Exp Med Biol; 1989; 253B():7-12. PubMed ID: 2558549
[No Abstract] [Full Text] [Related]
4. Antitumor and antiviral activity of synthetic alpha- and beta-ribonucleosides of certain substituted pyrimido[5,4-d]pyrimidines: a new synthetic strategy for exocyclic aminonucleosides.
Sanghvi YS; Larson SB; Matsumoto SS; Nord LD; Smee DF; Willis RC; Avery TL; Robins RK; Revankar GR
J Med Chem; 1989 Mar; 32(3):629-37. PubMed ID: 2918511
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pharmacology of anticancer agents [Part 5] Antimetabolites (2)].
Nakamura T; Ueda T; Uchida M
Gan To Kagaku Ryoho; 1992 Mar; 19(3):409-20. PubMed ID: 1543370
[TBL] [Abstract][Full Text] [Related]
6. The PRPP synthetase spectrum: what does it demonstrate about nucleotide syndromes?
Duley JA; Christodoulou J; de Brouwer AP
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1129-39. PubMed ID: 22132967
[TBL] [Abstract][Full Text] [Related]
7. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
Rustum YM; Danhauser L; Luccioni C; Au JL
Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
[TBL] [Abstract][Full Text] [Related]
8. Biochemical pharmacology and antitumor properties of 4-amino-8-[beta-D-ribofuranosylamino]pyrimido-[5,4-d]pyrimidine.
Jackson RC; Boritzki TJ; Cook PD; Hook KE; Leopold WR; Fry DW
Adv Enzyme Regul; 1989; 28():185-99. PubMed ID: 2560325
[TBL] [Abstract][Full Text] [Related]
9. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase.
Willis RC; Nord LD; Fujitaki JM; Robins RK
Adv Enzyme Regul; 1989; 28():167-82. PubMed ID: 2560324
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
